pentoxifylline has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we discussed the combined effects of CDDP and caffeine or pentoxifylline using human osteosarcoma cells (OST strain)." | 3.67 | [DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors]. ( Sasaki, T; Tomita, K; Tsuchiya, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomita, K | 1 |
| Tsuchiya, H | 1 |
| Sasaki, T | 1 |
1 other study available for pentoxifylline and Osteosarcoma
| Article | Year |
|---|---|
[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cell Division; | 1989 |